Abstract
Nearly 100 years ago, the pathogenesis of diabetes mellitus was linked to the pancreas [1]. Later, at the beginning of this century, some investigators reported islet lesions in diabetic individuals which included fibrosis, hyalinosis, hydropic degeneration, atrophy and inflammatory reactions [2]. However, the islets of Langerhans were yet to be linked to the production of insulin and the etiology and pathogenesis of diabetes remained unclear. Insulin was extracted from the pancreas in 1921 and proved to ameliorate most of the diabetic symptoms [3]. It soon became clear, however, that insulin was not a cure for diabetes. In 1965, Gepts [4] reported that the major morphologic alteration in the pancreas at the onset of IDDM was a disruption of the architecture of the islets of Langerhans and a loss of B-cells. The number of B-cells was reduced to less than 10% of normal values and in 68% of the pancreases examined, the islets were infiltrated by mononuclear cells. Islet inflammation, insulitis, was therefore suggested to be of pathogenetic importance [4–7]. Infiltration of the islets of Langerhans has also been associated with experimental diabetes induced by immunization with insulin [8–9], by multiple injections of low-dose streptozotocin [10], or following infection with diabetogenic viruses [11,12].
Keywords
- Major Histocompatibility Complex
- Islet Cell
- Islet Cell Antibody
- Insulin Autoantibody
- Juvenile Diabetes Mellitus
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
The work in the authors’ laboratory has been supported by the foundation Nordisk Insulinlaboratorium, The National Institutes of Health (grants DK26190, DK33873), and the Juvenile Diabetes Foundation. Steinunn Baekkeskov is supported by a Juvenile Diabetes Foundation Career Development Award.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
von Mering J, Minkowski O (1889) Diabetes Mellitus nach Pankreasextirpation. Arch Exp Pathol Pharmacol 26: 371–387
Gepts W, Pipeleers D (1976) The endocrine pancreas. Functional morphology and histopathology. In: Luft R (ed) Insulin. Acta Med Scand [Suppl] 601: 9–52
Banting FG, Best CB, Collip JB, Cambell WR, Fletcher AA (1922) Pancreatic extract in the treatment of diabetes mellitus. Can Med Assoc J 2:141–146
Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14: 619–633
Foulis AK, Stewart JA (1984) The pancreas in recent-onset Type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated/changes in the exocrine acinar tissue. Diabetologia 26: 456–461
Bottazzo GF, Dean BM, McNally JM, McKay EH, Swift PGF, Gamble DR (1985) In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313: 353–360
Rahier J, Goebbels RM, Henquin JC (1983) Cellular composition of the human diabetic pancreas. Diabetologia 24: 366–371
Lacy PE, Wright PH, Silverman JL (1963) Eosinophilic infiltration in the pancreas of rats injected with anti-insulin serum. Fed Proc 22: 60
Renold AE, Soeldner JS, Steincke J (1964) Immunologic studies with homologous and heterologous pancreatic insulin in the cow. Ciba Foundations Colloquia 15: 122
Like AA, Rossini AA (1976) Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193: 415–417
Craighead JE (1975) The role of viruses is the pathogenesis of pancreatic disease and diabetes mellitus. Prog Med Virol 19:161–214
Notkins AL (1977) Virus-induced diabetes mellitus. Brief review. Arch Virol 54:1–17
Nerup J, Andersen OO, Bendixen G, Egeberg J, Poulsen JE (1973) Antipancreatic, cellular hypersensitivity in diabetes mellitus. Antigenic activity of fetal calf pancreas and correlation with clinical type of diabetes. Acta Allergol 28: 223–230
Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet II: 1279–1283
Lernmark Å, Freedman ZR, Hofmann C, Rubenstein AH, Steiner DF, Jackson RL, Winter RJ, Traisman HS (1978) Islet cell surface antibodies in juvenile diabetes mellitus. N Engl J Med 299: 375–380
Platz P, Jackson BK, Morling M, Ryder LP, Svejgaard A, Thomsen M, Christy M, Kromann H, Benn J, Nerup J, Green A, Hauge M (1981) HLA-D and DR-antigens in genetic analysis of insulin-dependent diabetes mellitus. Diabetologia 21:100–115
Barbosa J, Chavers B, Dunsworth T, Michael A (1982) Islet cell antibodies and histocompatibility antigens (HLA) in insulin-dependent diabetes and their first degree relatives. Diabetes 31:585–588
Owerbach D, Lernmark Å, Platz P, Ryder LP, Rask L, Peterson PA, Ludvigson J (1983) HLA-D region β-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals. Nature 303: 815–817
Gepts W (1964) The cytologic pathology of the islets of Langerhans in juvenile diabetes. In: Brolin SE, Helman B and Knutson H (eds) The structure and metabolism of the pancreatic islets. Pergamon, Oxford, pp 513–519
Mancini AM, Costanzi G, Zampa GA (1964) Human insulin antibodies detected by immunofluorescence techniques. Lancet I: 726
Lendrum R, Walker JG (1975) Serum antibodies in human pancreatic disease. Gut 16: 365–371
MacCuish AC, Jordan J, Campbell CJ, Duncan LJP, Irvine WJ (1974) Antibodies to islet-cell in insulin-dependent diabetics with coexistent auto-immune disease. Lancet II: 1529–1533
Lendrum R, Walker G, Gamble DR (1975) Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lancet I: 880–883
Lendrum R, Walker GJ, Cudworth AG, Theophanides C, Pyke DA, Bloom A, Gamble DR (1975) Islet-cell antibodies in diabetes mellitus. Lancet II: 1273–1276
MacLaren NK, Huang SW, Fogh J (1975) Antibody to cultured human insulinoma cells in insulin-dependent diabetes. Lancet I: 997–1000
MacLaren NK (1977) Etiology and pathogenesis of insulin-dependent diabetes. Report from National Institute of Arthritis. Metab Dig Dis: 1–48
Lernmark Å (1974) The preparation of, and studies on, free cell suspensions from mouse pancreatic islets. Diabetologia 10: 431–438
Dobersen M J, Scharff JE, Ginsberg-Fellner F, Notkins AL (1980) Cytotoxic autoantibodies to β-cells in the serum of patients with insulin-dependent diabetes mellitus. N Engl J Med 303: 1493–1498
Van de Winkel M, Smets G, Gepts W, Pipeleers DG (1982) Islet cell surface antibodies from insulin-dependent diabetics bind specifically to pancreatic B-cells. J Clin Invest 70: 41–49
Lernmark Å, Baekkeskov S (1981) Islet cell antibodies — theoretical and practical implications. Diabetologia 21: 431–435
Bottazzo GF, Pujol-Borell R, Doniach D (1981) Humoral and cellular immunity in diabetes mellitus. Clin Immunol Allergy 1:139–159
Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J and Lernmark Å (1982) Autoantibodies in newly diagnosed diabetic children immunoprecipitate specific human pancreatic islet cell protein. Nature 298: 167–169
Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL (1983) Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222:1337–1339
McConnell I, Munro A, Waldmann H (1981) Autoimmune disease in the immune system — a course on the molecular and cellular basis of immunity, 2nd edn. Blackwell, London, pp 273
Ayoub EM, Barret DJ, MacLaren NK, Krischer JP (1986) Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest 77: 2019–2026
Weiss M, Ingbar SH, Winblad S, Kaspar DL (1983) Demonstration of a saturable binding site for thyrotropin in Yersinia enterocolitica. Science 219: 1331–1333
Waldmann TA, Broder S (1982) Polyclonal B-cell activators in the study of the regulation of immunoglobulin synthesis in the human system. Adv Immunol 48:196–200
Walls KW, Smith JW (1979) Serology of parasite infections. Int J Parasitol 10: 329–340
Perrin LH, Mackey LJ, Lambert PH (1985) Immunology of malaria. In: Rosse WF (ed) Clinical immunology update. Elsevier, New York, pp 234–264
Forsgren A, Sjöquist J (1966) Protein A from S. aureus. Pseudo-immune reaction with humanglobulin. J Immunol 97: 822–827
Björck L, Kronvall G (1984) Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J Immunol 133: 969–974
Vergani D (1986) Complement. Diabetic Med 3: 306–311
Todd I, Bottazzo GF (1985) Laboratory investigation of autoimmune endocrine diseases. Clin Immunol Allergy 5: 613–638
Bottazzo GF, Dean BM, Gorsueh AN, Cudworth AG, Doniach D (1980) Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage. Lancet I: 668–672
Srikanta S, Rabizadeh A, Omar MAK, Eisenbarth GS (1985) Assay for islet cell antibodies. Protein A-monoclonal antibody method. Diabetes 34: 300–305
Kobayashi T, Sugimoto T, Itoh T, Kosaka K, Tanaka T, Suwa S, Sato K, Tsuji K (1986) The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method. Diabetes 35: 335–340
Brogren CH, Lernmark Å (1982) Islet cell antibodies in diabetes mellitus. J Clin Endocrinol Metab 11:409–430
Eisenbarth GS (1986) Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314:1360–1368
Lernmark Å (1985) Molecular biology of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28:195–203
Bottazzo GF, Gleichmann H (1986) Immunology and diabetes workshops: report on the first international workshop on the standardisation of cytoplasmic islet cell antibodies. Diabetologia 29:125–126
Madsen OD, Landin Olsson M, Bille G, Sundkvist G, Lernmark Å, Dahlqvist G, Ludvigsson J (1986) A two-colour immunofluorescence test with a monoclonal human proinsulin antibody improves the assay for islet cell antibodies. Diabetologia 29:115–118
Eisenbarth GS, Morris MA, Scearce RM (1981) Cytotoxic antibodies to cloned rat islet cells in serum of patients with diabetes mellitus. J Clin Invest 67: 403–408
Yokono K, Shii K, Hari J, Yaso S, Imamura Y, Ejiri K, Ishihara K, Fujii S, Kazumi T, Taniguchi H, Baba S (1984) Production of monoclonal antibodies to islet cell surface antigens using hybridization of spleen lymphocytes from non-obese diabetic mice. Diabetologia 26:379–385
Matsuba I, Marner B, Nerup J, Lernmark Å (1987) Detection of islet cell autoantibodies in newly diagnosed diabetic patients using insulin-producing Syrian hamster cells. Diabetes Res 4:103–107
Grant Am, Harrison DE, Moysey L, Smith D, Ashcroft SJH (1985) Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies. Diabetes Res 2: 225–229
Pujol-Borrell R, Kouhry EL, Bottazzo GF (1982) Islet cell surface antibodies in Type 1 (insulin-dependent) diabetes mellitus: use of human fetal pancreas cultures as substrate. Diabetologia 22: 89–95
Contreas G, Madsen OD, Vissing H, Lernmark Å (1987) A simple assay for the detection of antibodies to endocrine islet cell surface antigens. J Immunol Methods 95:135–139
Huen A, Haneda M, Freedman Z, Lernmark Å, Rubenstein AH (1983) Quantitative determinations of islet cell surface antibodies using 125I-protein A. Diabetes 32: 460–465
Kanatsuna T, Baekkeskov S, Lernmark Å, Ludvigsson (1983) Immunoglobulin from insulin-dependent diabetic children inhibits glucose-induced insulin release. Diabetes 32: 520–524
Svenningsen A, Dyrberg T, Gerling I, Lernmark Å, Mackay P, Rabinovitch A (1983) Inhibition of insulin release after passive transfer of immunoglobulin from insulin-dependent diabetic children to mice. J Clin Endocrinol Metab 57:1301–1304
Lernmark Å, Sehlin J, Täljedal I-B, Kromann H, Nerup J (1978) Possible toxic effects of normal and diabetic patients serum on pancreatic beta-cells. Diabetologia 14: 25–31
Idahl L-Å, Sehlin J, Täljedal I-B, Thorneil L-E (1980) Cytotoxic activation of complement by mouse pancreatic islet cells. Diabetes 29: 636–642
Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M (1986) Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 232: 1545–1547
Rittenhouse HG, Oxender DL, Pek S, Ar D (1980) Complement-mediated cytotoxic effects on pancreatic islets with sera from diabetic patients. Diabetes 29: 317–322
Rabinovitch A, MacKay P, Ludvigsson J, Lernmark Å (1984) A prospective analysis of islet cell cytotoxic antibodies in insulin-dependent diabetic children: transient effects of plasmapheresis. Diabetes 33: 224–228
Toguchi Y, Ginsberg-Fellner F, Rubinstein P (1985) Cytotoxic islet cell surface antibodies (ICSA) in patients with type I diabetes and their first-degree relatives. Diabetes 34: 855–860
Marner B, Lernmark Å, Ludvigsson J, MacKay P, Matsuba I, Nerup J, Rabinovitch A (1985) Islet cell antibodies in insulin-dependent (Type I) diabetic children treated with plasmapheresis. Diabetes Res 2: 231–236
Smets G, Gepts W (1986) Selective complement fixation by pancreatic B-cells after binding to islet cell surface antibodies. J Endocrinol Invest 9: 43–49
Maruyama T, Takei I, Matsuba I, Tsuruoka A, Taniyama M, Ikeda Y, Kataoka K, Abe M, Matsuki S (1984) Cell-mediated cytotoxic islet cell surface antibodies to human pancreatic beta cells. Diabetologia 26: 30–33
Lernmark Å, Baekkeskov S, Dyrberg T, Gerling I, Marner B, Papadopoulos G, Svenningsen A, Binder C, Christy M, Nerup J, Mandrup-Poulsen T (1984) Pathogenesis of type I diabetes mellitus. In: Labrie F, Proulx L (eds) Endocrinology. Elsevier, Amsterdam, pp 92–96
Michaelis D, Rjasanowski I, Hehmke B, Kohnert K-D, Hildmann W, Keilacker H, Richter KV (1985) Lack of strong association between residual human C-peptide secretion and islet cell antibodies, complement-dependent antibody-mediated cytotoxicity, and HLA antigens in newly diagnosed type I diabetics. Biomed Biochim Acta 44: 99–106
Charles AM, Suzuki M, Waldeck N, Dodson LE, Slater L, Ong K, Kershnar A, Buckingham B, Golden M (1983) Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans. J Immunol 130:1189–1194
Weringer EJ, Like AA (1985) Immune attack on pancreatic islet transplant in the spontaneously diabetic Biobreeding/Worcester (BB/W) rat is not MHC restricted. J Immunol 134: 2383–2386
Baekkeskov S, Dyrberg T, Lernmark Å (1984) Autoantibodies against a Mr 64000 islet cell protein precede the onset of spontaneous diabetes. Science 224:1348–1350
Baekkeskov S, Braining S, Srikanta T, Mandrup-Poulsen T, Beaufort C, Eisenbarth GS, Lernmark Å (1986) Antibodies to a Mr 64000 human islet cell protein in the prediabetic period od IDDM patients. Ann NY Acad Sci 475: 415–417
Kanatsuna T, Baekkeskov S, Lernmark Å, Ludvigsson J (1983) Immunoglobulin from insulin-dependent diabetic children inhibits glucose-induced insulin release. Diabetes 32: 520–524
Arslanian SA, Becker DJ, Rabin B, Atchinson R, Eberhardt M, Cavender D, Dorsman J, Drash AL (1985) Correlates of insulin autoantibodies in newly diagnosed diabetic children with insulin-dependent diabetes before insulin therapy. Diabetes 34: 926–930
Wilkin T, Armitage M, Casey C, Pyke DA, Hoskins PJ, Rodier M, Diaz JL, Leslie RDG (1985) Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus. Lancet I: 480–482
Atkinson MA, MacLaren NK, Riley WJ, Winter WE, Fisk DD, Spillar RP (1986) Are insulin autoantibodies markers for insulin-dependent diabetes mellitus? Diabetes 35: 894–898
Soeldner JS, Tuttleman M, Srikanta S, Ganda OP, Eisenbarth GS (1985) Insulin-dependent diabetes mellitus and autoimmunity: islet cell autoantibodies, insulin autoantibodies and beta-cell failure. N Engl J Med 313: 893–894
Kaplan DR, Colca JR, McDaniel ML (1983) Insulin as a surface marker on isolated cells from rat pancreatic islets. J Cell Biol 97: 433–437
Baekkeskov S, Kanatsuna T, Klareskog L, Nielsen DA, Peterson PA, Rubenstein AH, Steiner DF, Lernmark Å (1981) Expression of major histocompatibility antigens on pancreatic islet cells. Proc Natl Acad Sci USA 78: 6456–6460
Faustman D, Hauptfeld V, Davie JM, Lacy PE, Schreffler DC (1980) Murine pancreatic-cells express H-2K and H-2D but not Ia antigens. J Exp Med 151: 1563–1568
Dean BM, Walker R, Bone AJ, Baird JD, Cooke A (1985) Pre-diabetes in the spontaneously diabetic BB/E rat: Lymphocyte subpopulations in the pancreatic infiltrate and expression of MHC class II molecules in endocrine cells. Diabetologia 28: 464–466
Contreas G, Lernmark Å, Mathiasen ER, Deckert T (1985) Immune complexes in insulin-dependent diabetes. Biomed Acta 44:129–132
Borsey DQ, Di Mario U, Irvine WJ, Gray SR, Guy K, Weston J, Pentherer J, Duncan LJP (1982) Humoral immunity in Type 1 diabetes mellitus: a prospective study. J Clin Lab Immunol 5: 9–15
Pipeleers DG, Pipeleers-Marichal MA (1981) A method for the purification of single A, B and D cells and for the isolation of coupled cells from isolated rat islets. Diabetologia 20: 654–663
Pipeleers DG, In’t Veld PA, Van de Winkel M, Maes E, Schmit FC, Gepts W (1985) A new in vitro model for the study of pancreatic A and B cells. Endocrinology 117: 806–816
Pipeleers D, van de Winkel M (1986) Pancreatic B cells possess defense mechanisms against cell-specific toxicity. Proc Natl Acad Sci USA 83: 5267–5271
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lernmark, Ä., Markholst, H., Baekkeskov, S. (1988). Circulating Signs of Autoimmune Islet Disease. In: Lefèbvre, P.J., Pipeleers, D.G. (eds) The Pathology of the Endocrine Pancreas in Diabetes. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72691-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-72691-0_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-72693-4
Online ISBN: 978-3-642-72691-0
eBook Packages: Springer Book Archive